XML 81 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Acquisitions and Divestitures - Acquisitions (Details) - USD ($)
$ in Millions
12 Months Ended
Nov. 01, 2022
Oct. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Discontinued Operations Disclosures          
Goodwill     $ 10,132 $ 9,947 $ 9,451
U.S. Pharmaceutical          
Discontinued Operations Disclosures          
Goodwill     4,123 4,050 $ 3,923
Rx Savings Solutions, LLC          
Discontinued Operations Disclosures          
Fair value adjustment gain     78    
Rx Savings Solutions, LLC | RxTs Segment          
Discontinued Operations Disclosures          
Business acquisition, percentage of controlling interest in combined business 100.00%        
Cash payment to acquire business $ 600        
Contingent consideration 92        
Other current liabilities     14 $ 83  
Other non-current liabilities     $ 9    
Acquired identifiable intangible assets $ 229        
Weighted average life of intangibles 12 years        
Goodwill $ 463        
Rx Savings Solutions, LLC | RxTs Segment | Maximum          
Discontinued Operations Disclosures          
Contingent consideration $ 275        
SCRI Oncology, LLC | U.S. Pharmaceutical          
Discontinued Operations Disclosures          
Business acquisition, percentage of controlling interest in combined business   51.00%      
Cash payment to acquire business   $ 166      
Acquired identifiable intangible assets   $ 177      
Weighted average life of intangibles   17 years      
Goodwill   $ 113      
Goodwill, expected tax deductible amount   46      
Noncontrolling interest   225      
SCRI Oncology, LLC | U.S. Pharmaceutical | SCRI          
Discontinued Operations Disclosures          
Noncontrolling interest   202      
SCRI Oncology, LLC | U.S. Pharmaceutical | USOR          
Discontinued Operations Disclosures          
Noncontrolling interest   $ 23